Interferon-alpha activity in a case of severe autoimmune lymphoproliferative disease

Ann Hematol. 2001 Jan;80(1):49-52. doi: 10.1007/s002770000228.

Abstract

Autoimmune lymphoproliferative disease (ALD) is a rare familial disorder. Clinical and laboratory features of this disease include a generalized lymphadenopathy, splenomegaly, increased levels of circulating CD3+ with low levels of CD4+, CD8+ T-cells, and autoimmune phenomena, characteristics that the autoimmune lymphoproliferative syndrome (ALPS) have in common. Treatment usually consists of different supportive therapies. We report on the case of a young man affected by ALD who became resistant to steroids and was unresponsive to cyclosporine. Nevertheless, he was successfully treated with interferon (IFN)-alpha, resulting in a long-lasting, clinically complete remission.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Autoimmune Diseases / drug therapy*
  • Humans
  • Interferon-alpha / therapeutic use*
  • Lymphoproliferative Disorders / drug therapy*
  • Lymphoproliferative Disorders / immunology
  • Male

Substances

  • Interferon-alpha